Eliezer Katz

Chief Tech/Sci/R&D Officer at ELEDON PHARMACEUTICALS, INC.

Health Technology

Health Services

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Steven Perrin	M	59	ELEDON PHARMACEUTICALS, INC.	4 years
Bryan Smith	M	45	ELEDON PHARMACEUTICALS, INC.	3 years
Keith Katkin	M	52	ELEDON PHARMACEUTICALS, INC.	7 years
Walter Ogier	M	67	ELEDON PHARMACEUTICALS, INC.	4 years
John McBride	M	72	ELEDON PHARMACEUTICALS, INC.	7 years
David-Alexandre Gros	M	51	ELEDON PHARMACEUTICALS, INC.	4 years
June Lee	M	58	ELEDON PHARMACEUTICALS, INC.	4 years
Jan Hillson	M	71	ELEDON PHARMACEUTICALS, INC.	3 years
Paul Little	M	60	ELEDON PHARMACEUTICALS, INC.	3 years
Allan Kirk	M	62	ELEDON PHARMACEUTICALS, INC.	1 years
Michael S. Curtis	M	-	eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	2 years
James Robinson	M	54	ELEDON PHARMACEUTICALS, INC.	1 years
David Hovland	M	-	ELEDON PHARMACEUTICALS, INC.	3 years
John Herberger	M	-	ELEDON PHARMACEUTICALS, INC.	2 years

Multi-company connection

Name	Gender	Age	Linked companies	Collaboration
Christian Nolet	M	67	VIELA BIO, INC.	2 years
Matthew J. Pietras	M	-	VIELA BIO, INC.	2 years
Andreas Wicki	M	64	VIELA BIO, INC.	3 years
Xiao Meng Tong	M	50	VIELA BIO, INC.	2 years
Pascal Soriot	M	64	VIELA BIO, INC.	1 years
Timothy Gray	M	54	Medimmune, Inc.	5 years
Jim Kastenmayer	M	52	VIELA BIO, INC.	1 years
Mitchell Chan	M	43	VIELA BIO, INC.	3 years
Harriet Robinson	M	86	University of Massachusetts Medical Center	9 years
Pauline Callinan	M	-	Medimmune, Inc.	4 years
Soraya Madani	M	-	VIELA BIO, INC.	2 years
Aaron Ren	M	46	VIELA BIO, INC.	2 years
Jörn Drappa	M	60	Medimmune, Inc.	7 years
Jacques Suzanne	F	53	VIELA BIO, INC.	1 years
Norman Michael Greenberg	M	64	Medimmune, Inc.	3 years
Steven Projan	M	72	Medimmune, Inc.	8 years
NgocDiep Le	M	56	Medimmune, Inc.	2 years
Yi Hong Yao	M	57	Medimmune, Inc.	4 years
Robert Steven Sikorski	M	-	Medimmune, Inc.	4 years
Jeffrey D. Bornstein	M	-	ELEDON PHARMACEUTICALS, INC.	2 years
Krishna Kandarpa	M	73	University of Massachusetts Medical Center	7 years
Laura Alessio	F	-	eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	1 years

Country	Connections	% of total
United States	36	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections